|Bid||36.81 x 1100|
|Ask||36.87 x 800|
|Day's Range||35.14 - 37.05|
|52 Week Range||35.14 - 64.37|
|Beta (5Y Monthly)||1.07|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Ionis (IONS) Q1 adjusted loss per share was wider than the year-ago figure. The company maintains its guidance for 2021.
IONS earnings call for the period ending March 31, 2021.
Ionis Pharmaceuticals reported a wider-than-expected loss for the first quarter, and also missed revenue estimates.